Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Photodynamic therapy and immunity.

D W Hunt1, A H Chan

  • 1QLT PhotoTherapeutics Inc, Vancouver, British Columbia, V5Z 4H5, Canada. dhunt@qlt-pdt.com

Idrugs : the Investigational Drugs Journal
|September 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An interpenetrating network composite for a regenerative spinal disc application.

Journal of the mechanical behavior of biomedical materials·2016
Same author

Majorana transport in superconducting nanowire with Rashba and Dresselhaus spin-orbit couplings.

Journal of physics. Condensed matter : an Institute of Physics journal·2015
Same author

Pheromone production by axenically rearedDendroctonus ponderosae andIps paraconfusus (Coleoptera: Scolytidae).

Journal of chemical ecology·2013
Same author

Sex-specific production of ipsdienol and myrcenol byDendroctonus ponderosae (Coleoptera: Scolytidae) exposed to myrcene vapors.

Journal of chemical ecology·2013
Same author

Partial inhibition of pheromone production inDendroctonus ponderosae (Coleoptera: Scolytidae) by polysubstrate monooxygenase inhibitors.

Journal of chemical ecology·2013
Same author

Response of mountain pine beetle,Dendroctonus ponderosae Hopkins, and pine engraver,Ips pint (SAY), to ipsdienol in southwestern British Columbia.

Journal of chemical ecology·2013
Same journal

Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.

IDrugs : the investigational drugs journal·2010
Same journal

Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.

IDrugs : the investigational drugs journal·2010
Same journal

LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.

IDrugs : the investigational drugs journal·2010
Same journal

Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.

IDrugs : the investigational drugs journal·2010
Same journal

Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.

IDrugs : the investigational drugs journal·2010
Same journal

Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.

IDrugs : the investigational drugs journal·2010
See all related articles

Photodynamic therapy (PDT) utilizes light-activated compounds to eliminate tumors and modulate immune responses. This approach shows potential in treating cancer and autoimmune diseases by targeting immune cells.

Area of Science:

  • Immunology
  • Oncology
  • Photochemistry

Background:

  • Photodynamic therapy (PDT) is a cancer treatment using light-activated compounds to generate cytotoxic oxygen species.
  • PDT has demonstrated immunomodulatory effects, including promoting anti-tumor immunity.
  • Paradoxically, PDT can also suppress immune responses in autoimmune models and skin sensitization.

Purpose of the Study:

  • To explore the dual role of photodynamic therapy (PDT) in cancer treatment and immune modulation.
  • To investigate how PDT influences immune responses in both anti-tumor and autoimmune contexts.
  • To understand the mechanisms underlying PDT's impact on T lymphocytes and antigen-presenting cells.

Main Methods:

  • Review of existing literature on photodynamic therapy (PDT) and its effects on immune systems.

Related Experiment Videos

  • Analysis of PDT's application in malignant tumor treatment.
  • Examination of PDT's effects in murine autoimmune models and chemical hapten sensitization.

    • Main Results:

    • PDT effectively treats accessible tumors by generating cytotoxic oxygen species.
    • PDT enhances anti-tumor immunity by recruiting immune cells like granulocytes and macrophages.
    • Lower light doses of PDT reduce disease severity in autoimmune models and inhibit immune reactions.

    Conclusions:

    • PDT exhibits a complex immunomodulatory capacity, acting as both an immunostimulant in cancer and an immunosuppressant in autoimmune conditions.
    • The effects of PDT on immune responses are linked to its ability to target activated T lymphocytes.
    • PDT influences the immunostimulatory properties of antigen-presenting cells, contributing to its diverse immune effects.